Folgen
Vincent Forster
Vincent Forster
Dr. sc. ETH Zürich
Bestätigte E-Mail-Adresse bei pharma.ethz.ch
Titel
Zitiert von
Zitiert von
Jahr
Liposome-supported peritoneal dialysis for detoxification of drugs and endogenous metabolites
V Forster, RD Signorell, M Roveri, JC Leroux
Science translational medicine 6 (258), 258ra141-258ra141, 2014
762014
Treatment of calcium channel blocker-induced cardiovascular toxicity with drug scavenging liposomes
V Forster, P Luciani, JC Leroux
Biomaterials 33 (13), 3578-3585, 2012
372012
3D strain map of axially loaded mouse tibia: a numerical analysis validated by experimental measurements
VA Stadelmann, J Hocké, J Verhelle, V Forster, F Merlini, A Terrier, ...
Computer methods in biomechanics and biomedical engineering 12 (1), 95-100, 2009
362009
Nano-antidotes for drug overdose and poisoning
V Forster, JC Leroux
Science translational medicine 7 (290), 290ps14-290ps14, 2015
302015
Liposome‐supported peritoneal dialysis for the treatment of hyperammonemia‐associated encephalopathy
V Agostoni, SH Lee, V Forster, M Kabbaj, CR Bosoi, M Tremblay, ...
Advanced functional materials 26 (46), 8382-8389, 2016
272016
Liposome-supported peritoneal dialysis in the treatment of severe hyperammonemia: An investigation on potential interactions
G Giacalone, S Matoori, V Agostoni, V Forster, M Kabbaj, ...
Journal of controlled release 278, 57-65, 2018
202018
Liposome-supported enzymatic peritoneal dialysis
A Pratsinis, S Zuercher, V Forster, EJ Fischer, P Luciani, JC Leroux
Biomaterials 145, 128-137, 2017
192017
Preclinical evaluation of liposome-supported peritoneal dialysis for the treatment of hyperammonemic crises
S Matoori, V Forster, V Agostoni, R Bettschart-Wolfensberger, RN Bektas, ...
Journal of Controlled Release 328, 503-513, 2020
82020
Liposome composition for use in peritoneal dialysis
JC Leroux, V Forster
US Patent 10,596,114, 2020
32020
SuO015 VS-01-A PROMISING INTRAPERITONEAL TREATMENT TO MANAGE HEPATIC ENCEPHALOPATHY AND RENAL FAILURE IN CIRRHOTIC PATIENTS
V Forster, V Agostoni, G Giacalone, S Lee, M Kabbaj, C Bosoi, ...
Nephrology Dialysis Transplantation 33 (suppl_1), i622-i622, 2018
12018
Injectable nano-antidotes (Nanotidotes) for the treatment of drug overdose and poisoning
V Forster, JC Leroux
12015
Drug-scavenging liposomes attenuate the cardiovascular toxicity of overdosed calcium channel blockers
V Forster, P Luciani, J Leroux
Biomaterials 33 (13), 3578-3585, 2012
12012
Design of a multi-scale canine-specific model of cardiac electromechanics: a step toward patient-specific modeling
V Forster
12008
Method for Preparing Transmembrane pH-Gradient Vesicles
JC Leroux, V Forster, V Agostoni
US Patent App. 17/831,071, 2022
2022
Method for preparing transmembrane pH-gradient vesicles
JC Leroux, V Forster, V Agostoni
US Patent 11,376,218, 2022
2022
Liposome composition for use in peritoneal dialysis
JC Leroux, V Forster
US Patent App. 17/018,438, 2021
2021
Liposome composition for use in peritoneal dialysis
JC Leroux, V Forster
US Patent App. 16/165,202, 2019
2019
VS-01-A PROMISING INTRAPERITONEAL TREATMENT TO MANAGE HEPATIC ENCEPHALOPATHY AND RENAL FAILURE IN CIRRHOTIC PATIENTS
V Forster, V Agostoni, G Giacalone, S Lee, M Kabbaj, C Bosoi, ...
NEPHROLOGY DIALYSIS TRANSPLANTATION 33, 1622-1622, 2018
2018
Drugs Interactions and Metabolomic Profile During Liposome-Supported Peritoneal Dialysis (LSPD) in the Treatment of Severe Hyperammonemia
G Giacalone, V Forster, V Agostoni, M Kabbaj, N Zamboni, JC Leroux
Journal of Clinical and Experimental Hepatology 7, S15, 2017
2017
Hyperammonemia: Liposome‐Supported Peritoneal Dialysis for the Treatment of Hyperammonemia‐Associated Encephalopathy (Adv. Funct. Mater. 46/2016)
V Agostoni, SH Lee, V Forster, M Kabbaj, CR Bosoi, M Tremblay, ...
Advanced Functional Materials 26 (46), 8357-8357, 2016
2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20